A treatment for Covid-19 involving monoclonal antibodies produced by Eli Lilly is being halted nationwide: bamlanivimab and etesevimab as a combination therapy. Monoclonal antibodies are lab-made proteins that “mimic the immune system’s ability to fight off harmful pathogens such as […]